Irinotecan HCl, an Anticancer Topoisomerase I Inhibitor, Frequently Induces Ovarian Failure in Premenopausal and Perimenopausal Women

Oncology Reports - Greece
doi 10.3892/or.19.5.1123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Evaluation of Predictive Symptoms of Ovarian Tumours in Perimenopausal and Postmenopausal Women

International Journal of Biomedical and Advance Research
2016English

Millepachine, a Potential Topoisomerase II Inhibitor Induces Apoptosis via Activation of NF-κB Pathway in Ovarian Cancer

Oncotarget
Oncology
2016English

CKD-602, a Topoisomerase I Inhibitor, Induces Apoptosis and Cell-Cycle Arrest and Inhibits Invasion in Cervical Cancer

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

A Comparative Study of Serum Lipid Profile and Premenopausal, Perimenopausal and Post-Menopausal Healthy Women: Hospital Based Study in Jharkhand, India

International Journal of Contemporary Medical Research [IJCMR]
2018English

Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan

Clinical Cancer Research
Cancer ResearchOncology
2006English

Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor

British Journal of Cancer
Cancer ResearchOncology
1996English

Health Concerns of Perimenopausal Women

International Journal of Studies in Nursing
2020English

Estradiol Level and Psychosocial Stress in Perimenopausal Women

Indonesian Journal of Obstetrics and Gynecology
2019English

Changes in Ovarian Stromal Function and Associated Symptoms in Premenopausal Women Undergoing Chemotherapy for Breast Cancer

2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy